25.17
Precedente Chiudi:
$25.24
Aprire:
$25.18
Volume 24 ore:
281.30K
Relative Volume:
0.31
Capitalizzazione di mercato:
$3.09B
Reddito:
$1.80B
Utile/perdita netta:
$15.62M
Rapporto P/E:
209.75
EPS:
0.12
Flusso di cassa netto:
$118.36M
1 W Prestazione:
+4.11%
1M Prestazione:
+12.88%
6M Prestazione:
+5.55%
1 anno Prestazione:
+39.12%
Privia Health Group Inc Stock (PRVA) Company Profile
Nome
Privia Health Group Inc
Settore
Industria
Telefono
571-366-8850
Indirizzo
950 N. GLEBE RD., SUITE 700, ARLINGTON
Confronta PRVA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
PRVA
Privia Health Group Inc
|
25.18 | 3.04B | 1.80B | 15.62M | 118.36M | 0.12 |
![]()
VEEV
Veeva Systems Inc
|
290.73 | 47.15B | 2.97B | 809.93M | 1.33B | 4.8743 |
![]()
TEM
Tempus Ai Inc
|
91.31 | 15.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
67.11 | 12.55B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
89.39 | 8.10B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
36.46 | 6.99B | 906.14M | -52.62M | 89.62M | -0.3621 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-01-10 | Iniziato | Needham | Buy |
2024-12-16 | Iniziato | Macquarie | Outperform |
2024-10-11 | Iniziato | KeyBanc Capital Markets | Overweight |
2024-05-30 | Iniziato | Robert W. Baird | Outperform |
2024-04-22 | Iniziato | Citigroup | Buy |
2024-03-06 | Iniziato | Barclays | Equal Weight |
2024-02-26 | Ripresa | Jefferies | Buy |
2024-02-22 | Downgrade | BofA Securities | Buy → Neutral |
2023-12-06 | Iniziato | JMP Securities | Mkt Outperform |
2023-06-13 | Iniziato | Evercore ISI | Outperform |
2023-04-12 | Iniziato | Stephens | Overweight |
2023-03-10 | Iniziato | RBC Capital Mkts | Outperform |
2023-02-03 | Iniziato | Goldman | Buy |
2022-12-09 | Iniziato | Stifel | Buy |
2022-12-08 | Iniziato | UBS | Buy |
2022-09-07 | Ripresa | Truist | Buy |
2022-05-03 | Iniziato | BofA Securities | Buy |
2022-04-28 | Iniziato | BTIG Research | Buy |
2022-04-01 | Ripresa | Credit Suisse | Outperform |
2022-03-30 | Iniziato | Guggenheim | Buy |
2022-02-22 | Aggiornamento | Cowen | Market Perform → Outperform |
2022-01-03 | Iniziato | Jefferies | Buy |
2021-09-27 | Iniziato | SVB Leerink | Outperform |
2021-09-10 | Iniziato | Cowen | Market Perform |
2021-05-24 | Iniziato | Canaccord Genuity | Buy |
2021-05-24 | Iniziato | Credit Suisse | Outperform |
2021-05-24 | Iniziato | JP Morgan | Overweight |
2021-05-24 | Iniziato | Piper Sandler | Overweight |
2021-05-24 | Iniziato | Truist | Buy |
2021-05-24 | Iniziato | William Blair | Outperform |
Mostra tutto
Privia Health Group Inc Borsa (PRVA) Ultime notizie
Understanding Privia Health Group Inc.’s price movementJuly 2025 Trends & Safe Investment Capital Preservation Plans - newser.com
How Privia Health Group Inc. stock reacts to bond yieldsJuly 2025 Short Interest & AI Enhanced Trade Execution Alerts - newser.com
Maryland State Retirement & Pension System Has $709,000 Position in Privia Health Group, Inc. $PRVA - Defense World
How sustainable is Privia Health Group Inc. stock dividend payoutSell Signal & Stock Market Timing Techniques - newser.com
How Privia Health Group Inc. stock benefits from global expansionWeekly Trend Summary & Low Risk High Win Rate Stock Picks - newser.com
How moving averages guide Privia Health Group Inc. trading2025 Risk Factors & Low Drawdown Momentum Ideas - newser.com
Can a trend reversal in Privia Health Group Inc. lead to recoveryTrade Volume Report & Daily Market Momentum Tracking - newser.com
Privia Health Group's (PRVA) Sell (D+) Rating Reaffirmed at Weiss Ratings - MarketBeat
Can Privia Health Group Inc. hit a new high this monthMarket Growth Report & Technical Analysis for Trade Confirmation - newser.com
Privia Health Group Inc. stock trend outlook and recovery pathWeekly Stock Summary & Daily Technical Stock Forecast Reports - newser.com
Using data filters to optimize entry into Privia Health Group Inc.July 2025 Price Swings & Verified Entry Point Signals - newser.com
Privia Health Group, Inc. (NASDAQ:PRVA) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Assessing Privia Health Group (PRVA) Valuation After 41% One-Year Return - Yahoo Finance
PRVA: Barclays Raises Price Target for Privia Health to $22.00 | - GuruFocus
Privia Health’s SWOT analysis: capital-efficient model drives stock growth By Investing.com - Investing.com Australia
Privia Health’s SWOT analysis: capital-efficient model drives stock growth - Investing.com
Privia Health to Report Third Quarter 2025 Results on Thursday, November 6 - MarketScreener
Nov 6: Q3 2025 results at 7:00 AM ET — Privia Health to host 8:00 AM ET earnings call - Stock Titan
111 Capital Invests $413,000 in Privia Health Group, Inc. $PRVA - MarketBeat
What momentum shifts mean for Privia Health Group Inc.Market Performance Report & Weekly Breakout Opportunity Watchlist - newser.com
Privia Health Group Inc. stock momentum explainedJuly 2025 Drop Watch & Free Community Supported Trade Ideas - newser.com
State of Alaska Department of Revenue Acquires 5,223 Shares of Privia Health Group, Inc. $PRVA - Defense World
Using RSI to spot recovery in Privia Health Group Inc.Earnings Overview Report & Fast Gaining Stock Strategy Reports - newser.com
Tools to assess Privia Health Group Inc.’s risk profileJuly 2025 Trends & Low Risk Growth Stock Ideas - newser.com
Privia Health Group Inc Stock Analysis and ForecastStock Market Trends & See Risk Factors Before Making Any Move - earlytimes.in
Privia Health Group, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Privia Health Group, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
Privia Health Group Inc Azioni (PRVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Privia Health Group Inc Azioni (PRVA) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Mehrotra Parth | Chief Executive Officer |
May 12 '25 |
Sale |
24.99 |
13,773 |
344,187 |
423,143 |
Mountcastle David | EVP & Chief Financial Officer |
May 12 '25 |
Sale |
24.99 |
3,322 |
83,017 |
172,909 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):